Clinic
Clearfield Hospital
Clearfield Hospital was paid $543K by Medicaid between Oct 2018 and Jun 2021, across 113 billing codes. Its largest line is 99285, emergency room visit (most serious) — 13% of everything it billed.
33Billing provider infoCLEARFIELD HOSPITAL
CLEARFIELD, PA 16830
CLEARFIELD, PA 16830
33aNPI1245402411assigned 03/28/2008
33bProvider typeClinic/Center
28Total paid$543K
24GClaims21,840
24DCodes billed113
24AFirst – last monthOct 2018 – Jun 2021
Compared with peers
Next to other Clinic/Center providers in Pennsylvania
Rank by total paid#85 of 176
Median peer was paid$441K
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 70 | $0.00 | |
| 2019 | 1,038 | $14K | |
| 2020 | 10,686 | $261K | |
| 2021 | 10,046 | $269K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 630 | 584 | $73K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 725 | 678 | $65K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 11% | 1,464 | 497 | $58K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 761 | 707 | $54K |
| 87631 | 4.3% | 171 | 165 | $23K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.0% | 247 | 238 | $22K |
| 80050 | General health panel | 3.5% | 412 | 398 | $19K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.0% | 101 | 98 | $16K |
| 80053 | Comprehensive metabolic panel | 2.5% | 1,316 | 1,113 | $14K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.5% | 340 | 327 | $14K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.2% | 199 | 187 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 1,687 | 1,369 | $9K |
101 more codes
| 80061 | Lipid panel | 1.6% | 647 | $9K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.6% | 289 | $9K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 156 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 368 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.3% | 330 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 533 | $5K |
| 83735 | <1% | 615 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 53 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 473 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 270 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 166 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 166 | $4K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 67 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 491 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 45 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 33 | $3K |
| 84702 | <1% | 171 | $3K | |
| 84439 | <1% | 338 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 307 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 369 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 117 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 118 | $2K |
| 84484 | <1% | 270 | $2K | |
| 85027 | <1% | 285 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 153 | $2K |
| 81001 | <1% | 705 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 320 | $2K |
| 87480 | <1% | 77 | $2K | |
| 83880 | <1% | 62 | $2K | |
| 87077 | <1% | 228 | $2K | |
| 87660 | <1% | 77 | $2K | |
| 80320 | <1% | 147 | $2K | |
| 80076 | <1% | 194 | $2K | |
| 83721 | <1% | 159 | $2K | |
| 82607 | <1% | 122 | $2K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 51 | $2K |
| 76830 | Ultrasound, transvaginal | <1% | 30 | $1K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 33 | $1K |
| 82728 | <1% | 108 | $1K | |
| 73564 | <1% | 62 | $1K | |
| 87186 | <1% | 152 | $1K | |
| 83690 | <1% | 258 | $1K | |
| 83605 | <1% | 173 | $1K | |
| 0001A | <1% | 34 | $1K | |
| 85730 | <1% | 187 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 16 | $1K |
| 82570 | <1% | 148 | $1K | |
| 87081 | <1% | 188 | $1K | |
| 82043 | <1% | 125 | $1K | |
| 85610 | <1% | 317 | $1K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 43 | $893.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 119 | $892.55 |
| 82784 | <1% | 28 | $843.19 | |
| 0002A | <1% | 19 | $800.00 | |
| 87040 | <1% | 47 | $788.20 | |
| 97161 | <1% | 12 | $760.67 | |
| 73630 | <1% | 64 | $728.55 | |
| 73610 | <1% | 41 | $717.00 | |
| 82746 | <1% | 60 | $709.20 | |
| 84100 | <1% | 110 | $705.06 | |
| 73110 | <1% | 55 | $664.15 | |
| 85652 | <1% | 191 | $567.00 | |
| 86618 | <1% | 21 | $543.69 | |
| 73030 | <1% | 37 | $538.20 | |
| 83615 | <1% | 72 | $537.86 | |
| 0012A | <1% | 15 | $504.00 | |
| 84460 | <1% | 65 | $481.68 | |
| 72110 | <1% | 23 | $469.25 | |
| 84703 | <1% | 48 | $459.80 | |
| 84153 | <1% | 17 | $455.60 | |
| 84450 | <1% | 62 | $445.46 | |
| 81003 | <1% | 142 | $438.09 | |
| 84550 | <1% | 72 | $430.15 | |
| 85379 | <1% | 51 | $427.18 | |
| 84146 | <1% | 15 | $391.20 | |
| 96376 | <1% | 48 | $386.64 | |
| 86140 | <1% | 131 | $380.17 | |
| 83540 | <1% | 43 | $345.69 | |
| 82565 | <1% | 50 | $337.76 | |
| 73130 | <1% | 25 | $335.25 | |
| 81025 | <1% | 83 | $321.20 | |
| 74018 | <1% | 29 | $318.51 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 136 | $301.81 |
| 80329 | <1% | 37 | $278.19 | |
| 86038 | <1% | 17 | $277.50 | |
| 87510 | <1% | 53 | $270.72 | |
| 82550 | <1% | 33 | $250.96 | |
| 82105 | <1% | 12 | $220.00 | |
| 84520 | <1% | 31 | $166.90 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 57 | $121.95 |
| 82248 | <1% | 16 | $121.23 | |
| 86592 | <1% | 31 | $114.40 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 49 | $108.64 |
| 87070 | <1% | 16 | $97.29 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 207 | $94.87 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | $94.50 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 238 | $76.16 |
| 82150 | <1% | 15 | $66.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 39 | $19.56 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 18 | $10.96 |
| 36415 | Collection of venous blood by venipuncture | <1% | 127 | $3.30 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROWN, DANETTE (REIMBURSEMENT ANALYST)
| Provider | Location | Paid |
|---|---|---|
| Clearfield Hospital | Clearfield, PA | $614K |
| Clearfield Hospital | Clearfield, PA | $996.70 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.